Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers in Oxford have been awarded £1.8m in capital funding from the Department of Health and Social Care to expand their work to tackle the growing problem of antimicrobial resistance (AMR), including using whole genome sequencing to diagnose AMR.

The funding was awarded to the NIHR (National Institute of Health Research) Oxford Biomedical Research Centre (BRC) to introduce new technologies for faster, more cost-effective sequencing of micro-organisms.

Read more (Oxford BRC website)